Namandje Bumpus

Insider Reports History

Location
Salt Lake City, UT
Signature
/s/ Jonathan Golightly, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Namandje Bumpus:

Company Role Class Num Shares Value Price $ Report Date Ownership
RECURSION PHARMACEUTICALS, INC. Director Class A Common Stock 47,557 $214,482 $4.51 18 Jun 2025 Direct
RECURSION PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 22,016 18 Jun 2025 Direct

Insider Reports Filed by Namandje Bumpus

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RXRX RECURSION PHARMACEUTICALS, INC. 18 Jun 2025 2 $0 4 Director 23 Jun 2025, 17:23
RXRX RECURSION PHARMACEUTICALS, INC. 17 Mar 2025 2 $0 4 Director 19 Mar 2025, 16:27
RXRX RECURSION PHARMACEUTICALS, INC. 15 Mar 2025 0 $0 3 Director 19 Mar 2025, 16:26